Literature DB >> 25755229

When to say when: How aggressively to care for children with multiply relapsed cancer?

Jonathan M Marron1, Jennifer W Mack1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25755229      PMCID: PMC4433559          DOI: 10.1002/pbc.25476

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  10 in total

1.  Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals.

Authors:  Deborah Tomlinson; Ute Bartels; Janet Gammon; Pamela S Hinds; Jocelyne Volpe; Eric Bouffet; Dean A Regier; Sylvain Baruchel; Mark Greenberg; Maru Barrera; Hilary Llewellyn-Thomas; Lillian Sung
Journal:  CMAJ       Date:  2011-10-17       Impact factor: 8.262

2.  Declining childhood and adolescent cancer mortality.

Authors:  Malcolm A Smith; Sean F Altekruse; Peter C Adamson; Gregory H Reaman; Nita L Seibel
Journal:  Cancer       Date:  2014-05-22       Impact factor: 6.860

3.  The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists.

Authors:  Tammy I Kang; Kari Hexem; Russell Localio; Richard Aplenc; Chris Feudtner
Journal:  Pediatr Blood Cancer       Date:  2012-09-28       Impact factor: 3.167

4.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

5.  Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer.

Authors:  Deena R Levine; Liza-Marie Johnson; Belinda N Mandrell; Jie Yang; Nancy K West; Pamela S Hinds; Justin N Baker
Journal:  Cancer       Date:  2014-12-29       Impact factor: 6.860

6.  Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care.

Authors:  J Wolfe; N Klar; H E Grier; J Duncan; S Salem-Schatz; E J Emanuel; J C Weeks
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

7.  Family Refusal of Chemotherapy for Pediatric Cancer Patients: A National Survey of Oncologists.

Authors:  Michele L Nassin; Emily L Mueller; Curt Ginder; Paul M Kent
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

8.  Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?

Authors:  Gevorg Tamamyan; Martin Dominkus; Susanna Lang; Christopher Diakos; Edda Mittheisz; Ernst Horcher; Wolfgang Holter; Andreas Zoubek; Stefan Bielack; Leo Kager
Journal:  Pediatr Blood Cancer       Date:  2014-12-08       Impact factor: 3.167

9.  Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Detlev Branscheid; Dorothe Carrle; Godehard Friedel; Knut Helmke; Matthias Kevric; Gernot Jundt; Thomas Kühne; Rainer Maas; Rudolf Schwarz; Andreas Zoubek; Heribert Jürgens
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

10.  Parents' views of cancer-directed therapy for children with no realistic chance for cure.

Authors:  Jennifer W Mack; Steven Joffe; Joanne M Hilden; Jan Watterson; Caron Moore; Jane C Weeks; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

  10 in total
  2 in total

1.  Parent values and preferences underpinning treatment decision making in poor prognosis childhood cancer: a scoping review protocol.

Authors:  Helen Pearson; Faith Gibson; Anne-Sophie Emma Darlington
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

Review 2.  Parent values and preferences underpinning treatment decision-making in poor-prognosis childhood cancer: a scoping review.

Authors:  Helen Pearson H; Gemma Bryan; Catherine Kayum; Faith Gibson; Anne-Sophie Darlington
Journal:  BMC Pediatr       Date:  2022-10-14       Impact factor: 2.567

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.